Changshan Pharmaceutical announced that the company recently received a notice from the controlling shareholder Gao Shuhua to release the pledge of some of the company's shares. The number of shares released from pledge this time is 7 million shares, accounting for 0.76% of the company's total share capital and 2.49% of the shares held by it. The pledge holder is a pawnbroker company, and the release date is November 10, 2026. As of the disclosure date of the announcement, Gao Shuhua held 281 million shares, accounting for 30.54% of the company's total share capital; he pledged 166 million shares, accounting for 59.30% of his shares and 18.11% of the company's total share capital. Currently, Gao Shuhua's pledge risk is generally manageable, and there is no risk of closing the pledged shares.

Changshan Pharmaceutical announced that the company recently received a notice from the controlling shareholder Gao Shuhua to release the pledge of some of the company's shares. The number of shares released from pledge this time is 7 million shares, accounting for 0.76% of the company's total share capital and 2.49% of the shares held by it. The pledge holder is a pawnbroker company, and the release date is November 10, 2026. As of the disclosure date of the announcement, Gao Shuhua held 281 million shares, accounting for 30.54% of the company's total share capital; he pledged 166 million shares, accounting for 59.30% of his shares and 18.11% of the company's total share capital. Currently, Gao Shuhua's pledge risk is generally manageable, and there is no risk of closing the pledged shares.